ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis

Lan, Tian*; Tang, Tang; Li, Ying; Duan, Yingling; Yuan, Qin; Liu, Wen; Ren, Yuqing; Li, Ning; Liu, Xuenan; Zhang, Yu; Li, Xinglong; Jin, Guifang; Wang, Shengpeng; Guo, Jiao*广东药学院
PHYTOMEDICINE2023-9DOI: 10.1016/j.phymed.2023.154935
2被引12阅读
引用收藏
分享

摘要

Background: The Fufang-zhenzhu-tiaozhi formula (FTZ), a traditional Chinese medicine (TCM) commonly used to treat metabolic diseases, potentially impacts the microbial ecosystem. Increasing evidence suggests that polysaccharides, bioactive components of TCMs, have great potential on kinds of diseases such as DKD by regulating intestinal flora. @@@ Purpose: This study aimed to investigate whether the polysaccharide components in FTZ (FTZPs) have beneficial effects in DKD mice via the gut-kidney axis. @@@ Study design and methods: The DKD model in mice was established by streptozotocin combined with a high-fat diet (STZ/HFD). Losartan was used as a positive control, and FTZPs were administered at doses of 100 and 300 mg/kg daily. Renal histological changes were measured by H&E and Masson staining. Western blotting, quantitative real-time polymerase chain reaction (q-PCR) and immunohistochemistry were performed to analyze the effects of FTZPs on renal inflammation and fibrosis, which were further confirmed using RNA sequencing. Immunofluorescence was used to analyze the effects of FTZPs on colonic barrier function in DKD mice. Faecal microbiota transplantation (FMT) was used to evaluate the contribution of intestinal flora. 16S rRNA sequencing was utilized to analyze the composition of intestinal bacteria, and UPLC-QTOF-MS-based untargeted metabolomics was used to identify the metabolite profiles. @@@ Results: Treatment with FTZPs attenuated kidney injury, as indicated by the decreased urinary albumin/creatinine ratio and improved renal architecture. FTZPs downregulated the expression of renal genes associated with inflammation, fibrosis, and systematically blunted related pathways. FTZPs also restored the colonic mucosal barrier and increased the expression of tight junction proteins (E-cadherin). The FMT experiment confirmed the substantial contribution of the FTZPs-reshaped microbiota to relieving DKD symptoms. Moreover, FTZPs elevated the content of short-chain fatty acids (propionic acid and butanoic acid) and increased the level of the SCFAs transporter Slc22a19. Intestinal flora disorders caused by diabetes, including the growth of the genera Weissella, Enterococcus and Akkermansia, were inhibited by FTZPs treatment. Spearman's analysis revealed that these bacteria were positively correlated with indicators of renal damage. @@@ Conclusion: These results show that oral administration of FTZPs, by altering SCFAs levels and the gut microbiome, is a therapeutic strategy for the treatment of DKD.

学科与关键词

关键词
PolysaccharidesGut-kidney axisDiabetic kidney diseaseGut microbiotaShort-chain fatty acid
相关
加载中…
  • The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease
    Yang, Yi-Qi; Tan, Hai-Bo; Zhang, Xiao-Yu; Zhang, Yu-Zhen; Lin, Quan-You; Huang, Min-Yi; Lin, Zi-Yang; Mo, Jia-Zhi; Zhang, Yue; Lan, Tian; Bei, Wei-Jian; Guo, Jiao*Journal of Ethnopharmacology, 2022, 292: 115165.被引 14
  • Traditional Chinese Medicine Fufang-Zhenzhu-Tiaozhi capsule prevents renal injury in diabetic minipigs with coronary heart disease
    Song, Lixia; Wang, Ke; Yin, Jianying; Yang, Yiqi; Li, Bo; Zhang, Dongxing; Wang, Hong; Wang, Weixuan; Zhan, Wenjing; Guo, Caijuan; Gu, Zhanhui; Wang, Lexun; Zeng, Zhihuan; Bei, Weijian*; Rong, Xianglu; Guo, Jiao*Chinese Medicine, 2022, 17(1): 102.被引 2
  • Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota
    Hong, Jinni*; Fu, Tingting; Liu, Weizhen; Du, Yu; Bu, Junmin; Wei, Guojian; Yu, Miao; Lin, Yanshan; Min, Cunyun; Lin, Datao*DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16: 3707-3725.
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2023-09
卷期
第 118 卷
页码
154935
DOI
10.1016/j.phymed.2023.154935
语言
GERMAN
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82070590, 2019B030302005]; Major Basic and Applied Basic Research Projects in Guangdong Province of China; [81830113]

作者

  • L

    Lan, Tian (通讯) (第一作者)

    guangdong pharmaceut univ

  • T

    Tang, Tang

    guangdong pharmaceut univ

查看全部 14 位作者收起作者
  • L

    Li, Ying

    guangdong pharmaceut univ

  • D

    Duan, Yingling

    guangdong pharmaceut univ

  • Y

    Yuan, Qin

  • L

    Liu, Wen

  • R

    Ren, Yuqing

    guangdong pharmaceut univ

  • L

    Li, Ning

    guangdong pharmaceut univ

  • L

    Liu, Xuenan

    guangdong pharmaceut univ

  • Z

    Zhang, Yu

    guangdong pharmaceut univ

  • L

    Li, Xinglong

    guangdong pharmaceut univ

  • J

    Jin, Guifang

    guangdong pharmaceut univ

  • W

    Wang, Shengpeng

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417